Literature DB >> 24142733

Comparison of dosiology between three dimensional conformal and intensity-modulated radiotherapies (5 and 7 fields) in gastric cancer post-surgery.

Hong Ma1, Jun Han1, Tao Zhang2, Yang Ke1.   

Abstract

The purpose of this study was to compare the dose distribution of intensity-modulated radiotherapy (IMRT) in 7 and 5 fields as well as 3-D conformal radiotherapy (3D-CRT) plans for gastric cancer using dosimetric analysis. In 15 patients with gastric cancer after D1 resection, dosimetric parameters for IMRT (7 and 5 fields) and 3D-CRT were calculated with a total dose of 45 Gy (1.8 Gy/day). These parameters included the conformal index (CI), homogeneity index (HI), maximum dose spot for the planned target volume (PTV), dose-volume histogram (DVH) and dose distribution in the organs at risk (OAR), mean dose (Dmean), maximal dose (Dmax) in the spinal cord, percentage of the normal liver volume receiving more than 30 Gy (V30) and percentage of the normal kidney volume receiving more than 20 Gy (V20). IMRT (7 and 5 fields) and 3D-CRT achieved the PTV coverage. However, IMRT presented significantly higher CI and HI values and lower maximum dose spot distribution than 3D-CRT (P=0.001). For dose distribution of OAR, IMRT had a significantly lower Dmean and Dmax in spinal cord than 3D-CRT (P=0.009). There was no obvious difference in V30 of liver and V20 of kidney between IMRT and 3D-CRT, but 5-field IMRT showed lower Dmean in the normal liver than other two plans (P=0.001). IMRT revealed favorable tumor coverage as compared to 3D-CRT and IMRT plans. Specifically, 5-field IMRT plan was superior to 3D-CRT in protecting the spinal cord and liver, but this superiority was not observed in the kidney. Further studies are needed to compare differences among the three approaches.

Entities:  

Mesh:

Year:  2013        PMID: 24142733     DOI: 10.1007/s11596-013-1193-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  23 in total

1.  Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer.

Authors:  M A Hunt; M J Zelefsky; S Wolden; C S Chui; T LoSasso; K Rosenzweig; L Chong; S V Spirou; L Fromme; M Lumley; H A Amols; C C Ling; S A Leibel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-01       Impact factor: 7.038

2.  Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer.

Authors:  A Yuriko Minn; Annie Hsu; Trang La; Pamela Kunz; George A Fisher; James M Ford; Jeffrey A Norton; Brendan Visser; Karyn A Goodman; Albert C Koong; Daniel T Chang
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

3.  Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer.

Authors:  Edwin P M Jansen; Mark P Saunders; Henk Boot; Vera Oppedijk; Ria Dubbelman; Bridget Porritt; Annemieke Cats; Joep Stroom; Renato Valdés Olmos; Harry Bartelink; Marcel Verheij
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-08       Impact factor: 7.038

4.  D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.

Authors:  Mitsuru Sasako; Takeshi Sano; Seiichiro Yamamoto; Yukinori Kurokawa; Atsushi Nashimoto; Akira Kurita; Masahiro Hiratsuka; Toshimasa Tsujinaka; Taira Kinoshita; Kuniyoshi Arai; Yoshitaka Yamamura; Kunio Okajima
Journal:  N Engl J Med       Date:  2008-07-31       Impact factor: 91.245

5.  Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.

Authors:  Bhishamjit S Chera; Christina Rodriguez; Christopher G Morris; Debbie Louis; Daniel Yeung; Zuofeng Li; Nancy P Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-20       Impact factor: 7.038

6.  Optimization of dose distributions for adjuvant locoregional radiotherapy of gastric cancer by IMRT.

Authors:  Frank Lohr; Barbara Dobler; Sabine Mai; Brigitte Hermann; Uta Tiefenbacher; Petra Wieland; Volker Steil; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2003-08       Impact factor: 3.621

7.  Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.

Authors:  Eric Van Cutsem; Cornelius Van de Velde; Arnaud Roth; Florian Lordick; Claus-Henning Köhne; Stefano Cascinu; Matti Aapro
Journal:  Eur J Cancer       Date:  2008-01       Impact factor: 9.162

Review 8.  EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach.

Authors:  Oscar Matzinger; Erich Gerber; Zvi Bernstein; Philippe Maingon; Karin Haustermans; Jean François Bosset; Akos Gulyban; Philip Poortmans; Laurence Collette; Abraham Kuten
Journal:  Radiother Oncol       Date:  2009-04-15       Impact factor: 6.280

Review 9.  Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.

Authors:  S Hummel; E L Simpson; P Hemingway; M D Stevenson; A Rees
Journal:  Health Technol Assess       Date:  2010-10       Impact factor: 4.014

10.  Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy.

Authors:  Yu-Cheng Kuo; Ying-Ming Chiu; Wen-Pin Shih; Hsiao-Wei Yu; Chia-Wen Chen; Pei-Fong Wong; Wei-Chan Lin; Jeng-Jong Hwang
Journal:  Radiat Oncol       Date:  2011-06-21       Impact factor: 3.481

View more
  5 in total

1.  Protection of organs at risk during neoadjuvant chemoradiotherapy for gastric cancer based on a comparison between conformal and intensity-modulated radiation therapy.

Authors:  Leszek Hawrylewicz; Wojciech Leszczyński; Agnieszka Namysł-Kaletka; Iwona Bronclik; Jerzy Wydmański
Journal:  Oncol Lett       Date:  2016-05-26       Impact factor: 2.967

2.  Double-arc volumetric modulated therapy improves dose distribution compared to static gantry IMRT and 3D conformal radiotherapy for adjuvant therapy of gastric cancer.

Authors:  Tao Zhang; Zhi-Wen Liang; Jun Han; Jian-Ping Bi; Zhi-Yong Yang; Hong Ma
Journal:  Radiat Oncol       Date:  2015-05-19       Impact factor: 3.481

3.  Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy.

Authors:  Xin Wang; Yuan Tian; Yuan Tang; Zhi-Hui Hu; Jia-Jia Zhang; Gui-Shan Fu; Pan Ma; Hua Ren; Tao Zhang; Ning Li; Wen-Yang Liu; Hui Fang; Ye-Xiong Li; Jing Jin
Journal:  Oncotarget       Date:  2017-06-13

4.  Dosimetric Comparison of Three Different Radiotherapy Techniques in Antrum-Located Stomach Cancer

Authors:  Alparslan Serarslan; Nilgun Ozbek Okumus; Bilge Gursel; Deniz Meydan; Yalcin Dastan; Talat Aksu
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

Review 5.  Adjuvant chemoradiation for gastric carcinoma: State of the art and perspectives.

Authors:  A Schernberg; E Rivin Del Campo; B Rousseau; O Matzinger; M Loi; P Maingon; F Huguet
Journal:  Clin Transl Radiat Oncol       Date:  2018-03-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.